DNTH vs LYFT · rev $6.2M vs P/E 108, rev $5.79B
Dianthus Therapeutics Inc. (DNTH) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
DNTH currently screens at market cap $4.40B. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the DNTH and LYFT stock pages for the full models.
Not investment advice.